Skip to content

Clinical trials

Completed Liver Cirrhosis trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Cirrhosis Status: Completed Country / region: South Korea Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20113
20121
20134
20152
20161
20171
20181
20191
20222
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Boramae Hospital4
Chuncheon Sacred Heart Hospital3
Seoul National University Hospital3
AstraZeneca2
Atea Pharmaceuticals, Inc.1
Azienda Ospedaliera di Padova1
Dong-Gu Kim1
GlaxoSmithKline1
HK inno.N Corporation1
Hepatopancreatobiliary Surgery Institute of Gansu Province1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Cirrhosis23
Carcinoma, Hepatocellular3
Fibrosis3
Hepatitis B, Chronic3
Fatty Liver2
Hepatitis C, Chronic2
Hypertension, Portal2
Liver Diseases, Alcoholic2
Non-alcoholic Fatty Liver Disease2
Acute Kidney Injury1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.